Short Stature Related Distress

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Idiopathic Short StatureSelf Image
Interventions
DRUG

GH treatment (Genotropin)

4 years treatment with GH

DRUG

1 year treatment with placebo followed by optional 3 years of GH treatment

1 year treatment with placebo followed by optional 3 years of GH treatment

Trial Locations (1)

49202

Schneider Children's Medical center, Petah Tikva

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Rabin Medical Center

OTHER